Rheumnow
Earlier treatment with biologics to reduce the risk of organ damage in systemic lupus erythematosus (SLE) Sponsored by GSK US Medical Affairs
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:07:54
- Mas informaciones
Informações:
Sinopsis
Learn about the importance of reducing organ damage and corticosteroid-associated toxicity in SLE, and how biologics may help to change the course of the disease by targeting its underlying mechanisms.
